Clinical Trials Directory

Trials / Completed

CompletedNCT02015273

To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ (ECOS Taiwan, Indonesia, Singapore)

Easypod Connect: a Multinational, Multicentre, Observational Study to Study Adherence and Long Term Outcomes of Therapy in Paediatric Subjects Using "easypodTM" Electromechanical Device for Growth Hormone Treatment

Status
Completed
Phase
Study type
Observational
Enrollment
82 (actual)
Sponsor
Merck KGaA, Darmstadt, Germany · Industry
Sex
All
Age
2 Years – 18 Years
Healthy volunteers
Not accepted

Summary

This is an Multinational, Multicenter, Observational Study to evaluate Adherence and Long Term Outcomes of Therapy in pediatric subjects using easypod™ electromechanical device for growth hormone treatment and to assess the level of adherence of subject receiving SAIZEN® via easypod™.

Detailed description

Subjects will be enrolled in a multicenter longitudinal observational study. Parents/subjects will provide their Informed Consent/assent to upload their data for population-based analyses and, ultimately, clinical outcomes. Adherence data will be primarily derived from the easypod™ device combined with physician data entry of outcome measures. Data will be collected both retrospectively and prospectively. This will allow the establishment of adherence profiles and explore the hypothesis that patient adherence support programs improve adherence and subsequent clinical outcomes. Collected data will be also analyzed in a multinational pooled analysis of comparable national studies. Primary Objective: • To assess the level of adherence of subjects receiving SAIZEN® via easypod™ Secondary Objectives: * To describe the impact of adherence on clinical outcomes for subject receiving SAIZEN® via easypod™ * To identify adherence subject profiling * To assess the impact of adherence on Insulin-like Growth Factor 1 (IGF1) (that is, above, below or within normal ranges)

Conditions

Interventions

TypeNameDescription
DEVICEeasypod™Saizen® (Somatropin) as per Summary of Product Characteristics administered by easypod™

Timeline

Start date
2014-02-28
Primary completion
2015-12-31
Completion
2015-12-31
First posted
2013-12-19
Last updated
2020-07-07

Locations

6 sites across 3 countries: Indonesia, Singapore, Taiwan

Source: ClinicalTrials.gov record NCT02015273. Inclusion in this directory is not an endorsement.